Sort
21,453 grants matching “tuberculosis”
Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology
$962,850Brianna Mullins · Salus Discovery, Llc · R44 · FY2022 · HD
Improving specificity of HPV Screen-and-Treat in South Africa
$962,232Louise Kuhn · Columbia University Health Sciences · UH3 · FY2017 · CA
Impact of HIV on the human alveolar environment drivingthe early events of Mycobacterium tuberculosis infection
$962,145Jordi B Torrelles · Texas Biomedical Research Institute · R01 · FY2025 · AI
Inflammation and Fibrosis in Pulmonary TB: the INFIN-TB Study
$962,133Sara Auld · Emory University · R01 · FY2022 · AI
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
$961,935Richard E Chaisson · Johns Hopkins University · U01 · FY2023 · AI
Safe Pregnancy by Infectious Disease Control in Kinshasa
$961,005University Of North Carolina Chapel Hill · U01 · FY2005 · HD
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
$960,557Galit Alter · Massachusetts General Hospital · R01 · FY2021 · AI
Point-of-care C-reactive protein-based tuberculosis screening in people living with HIV: a randomized trial
$960,438Christina Yoon · University Of California, San Francisco · R33 · FY2021 · HL
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
$960,396Sanjay Rajagopalan · Case Western Reserve University · R35 · FY2023 · ES
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
$960,396Sanjay Rajagopalan · Case Western Reserve University · R35 · FY2021 · ES
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
$960,396Sanjay Rajagopalan · Case Western Reserve University · R35 · FY2022 · ES
TUBERCULOSIS ELIMINATION AND LABORATORY
$959,816Joy Sennett · Mississippi State Department Of Health · U52 · FY2009 · PS
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2022 · AI
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$959,375Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2023 · AI
Component 2, pp. 145-169
$958,564Gerhard Wagner · Harvard Medical School · P01 · FY2015 · GM
Component 2, pp. 145-169
$958,564Gerhard Wagner · Harvard Medical School · P01 · FY2014 · GM
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$958,355Linda Jackson · Cabinet For Health And Family Services · U52 · FY2006 · PS
Novel Stem Cell Immunotherapy for MDR-Tuberculosis
$958,345Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2024 · AI
A Handheld Microchip for GC analysis of breath to screen for COVID-19
$957,641Xiao-An Fu · University Of Louisville · U18 · FY2022 · TR
Core 3: Biocontainment Research Support Services Core
$957,509Colin S. Duckett · Duke University · UC7 · FY2024 · AI
Safety and Tolerability of Ultra-short Course Rifapentine and Isoniazid (1HP) for Prevention of Tuberculosis in HIV-Uninfected Individuals
$957,056Richard E Chaisson · Johns Hopkins University · U01 · FY2022 · AI
Clinical Trial Site Monitoring for PHOENIx MDR-TB
$957,055Kimberly Smith · Ppd Development Lp · N01 · FY2024 · AI
WaNPRC MACACA NEMESTRINA SPF BREEDING COLONY
$956,922University Of Washington · U24 · FY2003 · RR
RP2: Targeting genes and pathways for autophagy-dependent inhibition of bacterial infection
$956,799Ramnik J Xavier · Ut Southwestern Medical Center · U19 · FY2020 · AI
Immunotherapeutics and vaccines against anthrax, plague and tularemia
$956,592Zheng W Chen · University Of Illinois At Chicago · U01 · FY2010 · AI